# Arbutus Biopharma (ABUS) — Analyst Forecast

ABUS · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/abus/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 1 | 0 | 0 | 1 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Nov 14, 2025 | Chardan Capital | Maintained | Buy | $5.00 |
| Aug 11, 2025 | Chardan Capital | Maintained | Buy | $5.00 |
| Mar 28, 2025 | Chardan Capital | Maintained | Buy | $5.00 |
| Jan 21, 2025 | HC Wainwright & Co. | Maintained | Buy | $5.00 |
| Nov 20, 2024 | Chardan Capital | Maintained | Buy | $5.00 |
| Nov 18, 2024 | HC Wainwright & Co. | Maintained | Buy | $5.00 |
| Nov 7, 2024 | HC Wainwright & Co. | Maintained | Buy | $5.00 |
| Nov 6, 2024 | Chardan Capital | Maintained | Buy | $4.50 |
| Sep 5, 2024 | Jefferies | Maintained | Buy | $7.00 |
| Aug 2, 2024 | JMP Securities | Maintained | Market Outperform | $5.00 |
| Jun 7, 2024 | HC Wainwright & Co. | Maintained | Buy | $5.00 |
| Jun 6, 2024 | HC Wainwright & Co. | Maintained | Buy | $5.00 |
| Jun 5, 2024 | Chardan Capital | Maintained | Buy | $4.00 |
| May 3, 2024 | Chardan Capital | Maintained | Buy | $4.00 |
| Apr 4, 2024 | JMP Securities | Maintained | Market Outperform | $4.00 |
| Mar 1, 2024 | HC Wainwright & Co. | Maintained | Buy | $5.00 |
| Mar 1, 2024 | Chardan Capital | Maintained | Buy | $4.00 |
| Sep 12, 2023 | HC Wainwright & Co. | Maintained | Buy | $6.00 |
| Aug 4, 2023 | Chardan Capital | Maintained | Buy | $6.00 |
| Aug 4, 2023 | HC Wainwright & Co. | Maintained | Buy | $6.00 |

## Frequently Asked Questions

### Is ABUS a buy, sell, or hold?

Analysts covering Arbutus Biopharma currently average a Buy rating: 1 buy, 0 hold and 0 sell, from 1 analyst. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on ABUS?

On Nov 14, 2025, Chardan Capital maintained Arbutus Biopharma at Buy with a price target of $5.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).